Voluntary nationwide recall: Potassium (Bluepoint – June)

Aug. 2024Pharmacy Updates

BluePoint Laboratories is recalling 21 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. Potassium Chloride is used for the treatment of low potassium.

This drug is being recalled because the product failed to dissolve in the body. This may cause high potassium levels, which can result in irregular heartbeat that can lead to cardiac arrest.

As of the date of BluePoint’s recall announcement, June 25, 2024, there have been no reports of adverse events related to this recall. Consult your health care provider before you stop using this product. To see if your medication was recalled, contact your doctor or pharmacy where you received the medication or visit the FDA website below.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Sedgwick at 1-855-695-8564. TTY users should call 711. Help is available Monday through Friday from 8 a.m. to 5 p.m. EST.
  • Visit the FDA website.

Recent Announcements

UPMC Health Plan Tapestry Link resources available

UPMC Health Plan Tapestry Link will launch on Tuesday, Dec. 1, 2026. To help ease your transition to the new platform, we have developed the following resources:
Nov. 2026Important Notices

Changes to inpatient denial and OBS claim billing

We will soon transition to the Epic® platform. This change will align our claims processing with industry standards by adjudicating claims based on the level of care authorized. As this transition approaches, please keep the following areas in mind:
Nov. 2026

Provider Services does not accept automated calls

Provider Services does not accept automated calls
Nov. 2026Important Notices